We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
MedXY AI/MedXY News/Section: Clinical Updates

What’s New in the ADA 2024 Standards of Care: Practical Guidance on Weight‑Lowering Drugs, Cardiorenal Protection, and Technology for Diabetes

MedXY Editorial Team•Oct 9, 2025•Clinical Updates
ADA 2024diabetesGLP-1SGLT2

Introduction and Context

The American Diabetes Association (ADA) publishes annual “Standards of Medical Care in Diabetes” to consolidate the latest evidence and provide actionable clinical recommendations. The 2024 Standards (Diabetes Care. 2024;47[S1]) arrive amid a rapid expansion of diabetes and obesity pharmacotherapy, growing evidence for cardiorenal protection from drug classes originally developed for glucose lowering, and wider adoption of diabetes technologies. These shifts created an urgent need to integrate new trial data and real-world considerations into clinical pathways.

Why this update matters now

MedXY registered readers

Sign in free to continue reading

Create or use your MedXY account to unlock the complete article.

This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Related articles

Open language-specific specialty feeds and department pages.

Mortality and Morbidity After Below-Knee Amputation in Diabetes: Insights from a 25-Year English Cohort StudyThis large-scale England study reveals persistently high mortality after below-knee amputation in diabetes, with one-year mortality exceeding 23%, emphasizing the need for targeted interventions focused on older, female, and comorbid patienSep 17, 2026Global Trends in the Burden of Ischemic Stroke Attributable to Diabetes Versus Atrial FibrillationThis study analyzes global trends comparing ischemic stroke burdens linked to diabetes and atrial fibrillation, revealing a rising impact of diabetes-related stroke and highlighting the need for targeted interventions.Sep 12, 2026Charcot Neuro-Osteoarthropathy in Diabetes: High Risk of Hospitalization, Amputation, and Mortality Revealed by Regional Cohort StudyCharcot neuro-osteoarthropathy (CNO) in people with diabetes is linked to frequent emergency hospitalizations, substantial risk of limb amputation, and reduced survival, highlighting urgent need for intensified multidisciplinary care.Sep 5, 2026
Loading comments...
MedXY briefing

Get the free newsletter

Evidence-led clinical news, trends, and analysis—delivered to your inbox.

Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
Intimate Health
What Makes a Woman "Physiologically Addicted" Is Never Money, But These Two Relationship Qualities
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
Bridging the Gap: Ensuring Outpatient Follow-Up After Emergency Department Visits for Diabetes
Less than half of diabetes patients discharged from the emergency department receive timely outpatient follow-up, underscoring critical care continuity gaps that require targeted interventions to improve outcomes.
Sep 1, 2026
Adult Overweight and Obesity Management: Key Updates from the 2025 VA/DoD Clinical Practice GuidelineA clear, clinician-focused summary of the 2025 VA/DoD guideline update: new screening thresholds, streamlined treatment pathways, integration of pharmacotherapy (including GLP‑1 receptor agonists), endoscopic and surgical options, and veterAug 27, 2026
Refining Diabetes Classification in East Asians: Harnessing Data-Driven Clusters for Precision MedicineThis article reviews data-driven diabetes subtypes in East Asians, highlighting unique pathological features, genetic influences, and complication risks, emphasizing personalized treatment strategies for optimized care.Aug 24, 2026